Global Drug-Eluting Stent Market Growth, Share, Size, Trends and Forecast (2025 - 2031)

By Coating;

Polymer Based Coating and Polymer Free Coating.

By Equipment;

Walking Frames & Rollators, Walking Stick/Crutches, Axillary Stick/Crutch, Elbow Stick/Crutch, Forearm Stick/Crutch, and Mobility Scooters.

By Geography;

North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2021 - 2031).
Report ID: Rn657710108 Published Date: January, 2025 Updated Date: February, 2025

Introduction

Global Drug-Eluting Stent Market (USD Million), 2021 - 2031

In the year 2024, the Global Drug-Eluting Stent Market was valued at USD 7,163.40 million. The size of this market is expected to increase to USD 11,427.81 million by the year 2031, while growing at a Compounded Annual Growth Rate (CAGR) of 6.9%.

The Global Drug-Eluting Stent Market is an essential segment of the medical device industry, focusing on devices used in the treatment of coronary artery diseases. Drug-eluting stents (DES) are small, mesh-like tubes implanted into coronary arteries to keep them open and ensure proper blood flow to the heart. These stents are coated with medication that is gradually released to prevent the growth of scar tissue, thereby reducing the risk of artery re-narrowing (restenosis).

The market for drug-eluting stents has grown significantly over the past few decades, driven by increasing incidences of cardiovascular diseases, advancements in stent technologies, and a growing aging population. Innovations such as biodegradable stents, polymer-free stents, and personalized stent solutions are shaping the future of the market. Additionally, the development of DES has substantially improved patient outcomes compared to traditional bare-metal stents, making them a preferred choice among cardiologists.

Despite the promising growth prospects, the market faces several challenges, including high costs, stringent regulatory requirements, and the availability of alternative treatments. However, ongoing research and development, coupled with rising healthcare investments and expanding healthcare access in emerging markets, present significant opportunities for future growth. The Global Drug-Eluting Stent Market is poised to evolve with continued innovation and increasing adoption of these life-saving devices.

  1. Introduction
    1. Research Objectives and Assumptions
    2. Research Methodology
    3. Abbreviations
  2. Market Definition & Study Scope
  3. Executive Summary
    1. Market Snapshot, By Equipment
    2. Market Snapshot, By Region
    3. Market Opportunity Map
  4. Global Drug-Eluting Stent Market Dynamics
    1. Drivers, Restraints and Opportunities
      1. Drivers
        1. Aging population growth
        2. Rising cardiovascular diseases
        3. Technological advancements adoption
        4. Favorable reimbursement policies
        5. Growing healthcare investments
      2. Restraints
        1. High product costs
        2. Stringent regulatory approvals
        3. Limited skilled professionals
        4. Adverse side effects
        5. Alternative treatment options
      3. Opportunities
        1. Emerging market expansion
        2. Technological innovation integration
        3. Personalized stent development
        4. Minimally invasive procedures
        5. Collaborative research initiatives
    2. PEST Analysis
      1. Political Analysis
      2. Economic Analysis
      3. Social Analysis
      4. Technological Analysis
    3. Porter's Analysis
      1. Bargaining Power of Suppliers
      2. Bargaining Power of Buyers
      3. Threat of Substitutes
      4. Threat of New Entrants
      5. Competitive Rivalry
  5. Market Segmentation
    1. Global Drug-Eluting Stent Market, By Coating, 2021 - 2031 (USD Million)
      1. Polymer Based Coating
      2. Polymer Free Coating
    2. Global Drug-Eluting Stent Market, By Equipment, 2021 - 2031 (USD Million)
      1. Walking Frames & Rollators
      2. Walking Stick/Crutches
      3. Axillary Stick/Crutch
      4. Elbow Stick/Crutch
      5. Forearm Stick/Crutch
      6. Mobility Scooters
    3. Global Drug-Eluting Stent Market, By Geography, 2021 - 2031 (USD Million)
      1. North America
        1. United States
        2. Canada
      2. Europe
        1. Germany
        2. United Kingdom
        3. France
        4. Italy
        5. Spain
        6. Nordic
        7. Benelux
        8. Rest of Europe
      3. Asia Pacific
        1. Japan
        2. China
        3. India
        4. Australia & New Zealand
        5. South Korea
        6. ASEAN (Association of South East Asian Countries)
        7. Rest of Asia Pacific
      4. Middle East & Africa
        1. GCC
        2. Israel
        3. South Africa
        4. Rest of Middle East & Africa
      5. Latin America
        1. Brazil
        2. Mexico
        3. Argentina
        4. Rest of Latin America
  6. Competitive Landscape
    1. Company Profiles
      1. Abbott Laboratories
      2. Boston Scientific Corporation
      3. Medtronic plc
      4. Terumo Corporation
      5. Biosensors International Group, Ltd.
      6. Biotronik SE & Co. KG
      7. Cook Medical Inc.
      8. B. Braun Melsungen AG
      9. C. R. Bard, Inc.
      10. Lepu Medical Technology (Beijing) Co., Ltd.
  7. Analyst Views
  8. Future Outlook of the Market